Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Unique asthma medication launched in Canada

Sep. 1, 1998

Research on alpha2-agonists continues at P&G

Aug. 31, 1998

P&G reports alpha2-adrenoceptor agonists for treating nasal congestion

Aug. 28, 1998

Hoechst Marion Roussel and 3M file NDA for QVAR

Aug. 28, 1998

Glaxo Wellcome presents development candidate GW-311616A

Aug. 27, 1998

P&G claims alpha2-adrenoceptor agonists with a wide range of potential applications

Aug. 27, 1998

Novel antiinflammatory/antiallergy agents in the pipeline at Japan Energy

Aug. 27, 1998

Antiasthma drug candidate enters phase I testing at Pharmacia & Upjohn

Aug. 25, 1998

Pfizer selects LTB4 antagonist for clinical testing

Aug. 25, 1998

Japanese lab describes new agents for asthma and inflammation

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...